Introduction
Helicobacter pylori (H pylori) infection is the commonest chronic human bacterial infection and about 50% of adults the world over are said to be colonised with the pathogen. 1 The aetiologic agent is a flagellated spiralshaped Gram negative bacterium with its natural ecological niche being the antral portion of the human stomach. 2, 3 Its colonisation of the human gastric antrum has been associated with chronic gastroduodenal diseases worldwide. Manifestations of H. pylori associated gastroduodenal diseases have been reported principally in adulthood although the acquisition occurs in childhood. 1 Primary peptic ulcer disease has been shown to be associated with H. pylori infection in children. 4 There is a dearth of information on H. pylori associated clinical manifestations in children even though higher incidence rates are recorded in the socioeconomicallychallenged developing countries where over 50% of children are infected by five years of age. [5] [6] [7] [8] [9] The clinical course of H. pylori infection is highly variable. This is influenced by the microbial, host and environmental factors. The dynamics of this global infection are different for different regions but in virtually all infected individuals, H. pylori infection causes a chronic inflammation of the gastric mucosa. Gastritis develops rapidly after acquisition of H. pylori infection and remains with the persistence of the infection. 10 This gastritis is suggested to be a precursor of gastric cancer with obvious grave consequencies.
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In the adult population, acute H. pylori infection is accompanied by mild to moderate dyspeptic symptoms and occasional vomiting occurring within a few days of the challenge. These symptoms peak during the second week of illness and then resolve. 12 In children, the symptomatology of acute H. pylori infection is not well characterised. Occasionally, acute infection may cause gastric ulcers and haematemesis. 13 There is virtually no data on clinical manifestations of H. pylori infection in Nigerian children though the scanty available data show that the prevalence of this infection is very high. 5, 6 In Maiduguri, Holcombe et al reported age specific prevalence rates of 82% and 92% in children aged 5-10years and 11-19 years respectively. 5 This study was therefore undertaken to see whether or not the high seropositivity of H. pylori infection as reported in Nigerian children has any clinical correlates in children admitted for treatment of various ailments at a tertiary health centre in southern Nigeria.
Subjects and methods
The study was conducted at the University of Uyo Teaching Hospital, Uyo, in Akwa Ibom State. Akwa Ibom State has a population of 3.9 million people.
14 Uyo is the capital city of Akwa Ibom State. It is predominantly a civil service town. The Teaching Hospital is a 300 bed capacity hospital and the only tertiary health institution in the state.
The study population consisted of 230 children, admitted in the children emergency unit of our hospital, aged between six months and 15 years who required venepuncture, and for whom an informed written consent was obtained. The sample size was calculated using the formula n = Z 2 P(1-P) d A clinical history was obtained from each subject, including the family and social history and the child's socioeconomic status was determined using the parents/ guardians social class according to the social classification scheme proposed by Oyedeji. 15 A quick clinical examination, including oral and dental assessments, was also done. Standard anthropometric measurements were taken. These were recorded on the study proforma. About 2.0mls of blood was collected from each subject into a plain specimen bottle and taken to the laboratory within 30 minutes and centrifuged to separate the serum, which was stored frozen at -20 0 C till sufficient samples were pooled for analysis.
The VicTorch H pylori IgG test kit, with high sensitivity and specificity of 90-93% and 95-96% respectively, was used for the analysis as described by the manufacturer. 16 The reagents were stored unopened at 4 0 C. Repeated freezing and thawing of the samples or microbial contamination were avoided and icteric or turbid samples were not used (manufacturer's precautionary advice). The cut off value for positive antibody activity (AA) was taken at greater than 20IU. 16 A definite infection, as determined by the antibody activity of this test kit, was not less than 10% of the cut off value with accuracy level of 85.2%. 16 The test principle is based on appreciation of antibody titre with time and the 20IU is the level at which antibody build up determined a definite infection in comparison with urea breath test of gastric biopsy specimens.
Ethical approval was given by the Ethical Committee of the University Of Uyo Teaching Hospital, Uyo.
Statistical analyses
Statistical analyses were performed using the SPSS software package (Statistical Package for Social Sciences) 15.0 Software. Data were summarised into tables. The seropositivity for H. pylori was computed according to age. Correlates of H. pylori were evaluated by a comparison of proportions of children with and without infection using Chi-square(x 2 ) test and Fisher's exact test as appropriate.
Controlling variables for evaluation with multiple logistic models were age, gender and symptoms. The statistical significance of the adjusted seropositive rates among comparison groups was also tested. p-value of ≤0.05 was the significant level.
Results
Two hundred and thirty children aged 6 months to 15 years with mean age of 5.0 (±4.0) years, median age of 4.0 years, comprising 132 (57.4%) males and 98 (42.6%) females had their serum samples tested for IgG antibody reaction to H. pylori.
Using the cut-off value for antibody activity (AA) of 20IU, 71 (30.9%) were serologically positive for H. pylori IgG antibodies while 159 (69.1%) were negative. The antibody activity (AA) level of seropositive children was >20.0IU with a mean (±SD) value of 42.0IU (±16.1) as given by the manufacturers.
The age distributions of the study subjects were as shown in Table 1 . Children less than five years of age constituted 60.0% of the subjects. H. pylori seropositivity was highest in the one to five years age group (36.6%) and the cumulative seropositivity was 56.3% in the under five years age group. The least represented age group was 11-15 years which constituted 12.2% of the study population with 9.9% seropositivity.
The general characteristics of the subjects namely; the mean age, weight, height and body mass index were HPAP =H. pylori Antibody Positive HPAN =H. pylori Antibody Negative Table 3 : Relationship between some symptoms and H. pylori seropositivity according to age group of subjects
Discussion
The seroprevalence rate of 30.9% obtained in this study is high and suggests that H. pylori infection is significant in the paediatric age group of the study locality. This is consistent with high prevalence rates reported among children in other developing countries. 5-9, 15, 17 Symptoms which were associated with H. pylori seropositivity included abdominal pains, fetor oris and diarrhoea.
The association of abdominal pains with H. pylori seropositivity has also been reported by other authors. 19, 20 This could be as a result of gastritis which has been reported to develop rapidly after acquisition of the infection and remains with the persistence of the infection. 10 Malatyet al 19 reported that the younger children who had recurrent abdominal pains were more likely than older children, to be infected with H. pylori. Also, in a forty year review article by Bittencourtet al, 20 it was stated that in the under-seven years old school children, abdominal pain was described in virtually all cases of H. pylori infection. These reports are comparable with our findings of higher occurrence of abdominal pain in the five -10 year olds.
Data from this study showed a significant association between diarrhoea and H. pylori seropositivity. Some other studies had also suggested that infection with H. pylori may predispose patients to other gastrointestinal infections. Passaroet al 21 reported that newly acquired H. pylori infection was followed with increased occurrence of diarrhoea. In contrast, the study by Rothenbacheret al 22 reported a significantly less occurrence of acute diarrhoeal illness in H. pylori infected children and adults, compared to uninfected subjects. It is difficult to exclude other confounding factors which may explain the conflicting reports of these observational studies.
The significance of fetor oris as seen in this study was also reported in the voluntary experimental ingestion of a pure culture of H. pylori by Marshall. 23 This symptom among others, was noted to have resolved completely within twenty four hours of the start of therapy with Tinidazole (500mg twice a day), for eradication of H. pylori. 20 The production of ammonia from urea by H. pylori which is a urease splitting organism has been documented to be the likely physiological basis of fetor oris in H. pylori infection. 24 There was no association between H. pylori seropositivity and the weight, height and body mass index of these subjects. The relationship of growth parameters and H. pylori infection in children as reported in previous studies has not showed a consistent pattern. The lack of association as seen in this study was also reported by Oderdaet al. 25 Their study did not show any risk for short stature in H. pylori infected children after controlling for the socioeconomic status of their families. In contrast, Chloe et al. 26 reported a significantly lower mean height in H. pylori infected school children in comparison to their uninfected counterparts.
Conclusion
The IgG seropositvity rate in our study population is high and shows positive association with clinical features such as fetor oris, abdominal pain and diarrhoea, as well as with a positive family history of dyspepsia. We recommend that children presenting with any combination of these features should be screened for H. pylori infection as early confirmation of infection in childhood with appropriate eradication therapy will impact positively on the reduction or prevention of long term sequelae of this treatable bacterial infection.
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